Health
New CRISPR system edits body’s response to prevent immunity against AAVs – Drug Target Review
A CRISPR system that suppresses AAV antibody production has been developed to prevent immunity against the gene therapy.
Posted: 4 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
A novel CRISPR system that suppresses genes related to adeno-associated virus (AAV) antibody production has been developed to prevent immunity against the gene therapy.
Researchers have created a new CRISPR system that suppresses genes related to adeno-associated virus (AAV) antibody production so that the virus can deliver its cargo unimpeded.
According to the researchers from the University of Pittsburgh School…
-
General13 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News17 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
Noosa News17 hours agoWest End icon closes doors
-
General19 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay